Medical Tech Firm Heartflow Prices $317 Million IPO Above Range

Aug. 8, 2025, 12:43 AM UTC

Heartflow Inc. raised $317 million in its initial public offering, pricing shares above the top of a marketed range.

The company, which is an artificial intelligence software platform focused on heart disease, sold 16.67 million shares at $19 each, according to a statement Thursday.

The Mountain View, California-based company had boosted the size and price range of the IPO to 16.67 million shares for $17 to $18 apiece, up from 12.5 million shares at $15 to $17 each, according to its filings with the US Securities and Exchange Commission.

At the IPO price, Heartflow would have a market value of ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.